CCL21 Polyklonale Antilichaam, FITC-vervoeging

Inhibits hemopoiesis and stimulates chemotaxis. Chemotactic in vitro for thymocytes and activated T-cells, but not for B-cells, macrophages, or neutrophils. Shows preferential activity towards naive T-cells. May play a role in mediating homing of lymphocytes to secondary lymphoid organs. Binds to atypical chemokine receptor ACKR4 and mediates the recruitment of beta-arrestin (ARRB1/2) to ACKR4.

ECL; SLC; CKb9; TCA4; 6Ckine; SCYA21; C-C motif chemokine 21; Beta-chemokine exodus-2; Secondary lymphoid-tissue chemokine; Small-inducible cytokine A21; CCL21; UNQ784/PRO1600

6366

O00585

Secreted

24-134/134

CCL21

FITC

KLH conjugated synthetic peptide derived from human CCL21

WB, IF (IHC-P)

Purified by Protein A.

494nm/518nm

1µg/µl

WB (1:300-5000), IF (IHC-P) (1:50-200)

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Unmodified

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

6366

Human, Mouse, Rat, Dog, Pig, Horse, Rabbit